C Jasmin
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 20
- Cancer Treatment and Pharmacology 9
- Colorectal Cancer Treatments and Studies 8
- Hematology 14
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- L Schwarzenberg (20 shared papers)Denis Clay (2 shared papers)G Mathé (16 shared papers)Florence Smadja‐Joffe (3 shared papers)Bertrand Delpech (2 shared papers)Yue Li (1 shared paper)Christine Chomienne (1 shared paper)N Balitrand (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Leukemia Research (2 papers)The Lancet (2 papers)Recent results in cancer research (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
C Jasmin
55 papers receiving 832 citations
Peers
Comparison fields: 5 of 101
- Hematology 170
- Oncology 364
- Immunology 194
- Genetics 81
- Pathology and Forensic Medicine 93
Countries citing papers authored by C Jasmin
This map shows the geographic impact of C Jasmin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Jasmin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Jasmin more than expected).
Fields of papers citing papers by C Jasmin
This network shows the impact of papers produced by C Jasmin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Jasmin. The network helps show where C Jasmin may publish in the future.
Co-authors
The 25 scholars most cited alongside C Jasmin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 136 | |
| 2 | Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. | 1982 | 102 |
| 3 | Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study. | 1989 | 91 |
| 4 | 1997 | 63 | |
| 5 | 1967 | 54 | |
| 6 | 1998 | 39 | |
| 7 | Importance of age and methotrexate dosage: prognosis in children and young adults with high-grade osteosarcomas. | 1988 | 35 |
| 8 | 1999 | 32 | |
| 9 | 1973 | 25 | |
| 10 | Immunoblastic acute lymphoid leukaemia. | 1974 | 25 |
| 11 | 1990 | 23 | |
| 12 | A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer. | 1995 | 19 |
| 13 | 1999 | 16 | |
| 14 | 1969 | 16 | |
| 15 | Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial. | 1982 | 15 |
| 16 | BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. | 1973 | 15 |
| 17 | 1977 | 13 | |
| 18 | Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trial. | 1982 | 11 |
| 19 | [Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias]. | 1970 | 11 |
| 20 | 1984 | 10 |
About C Jasmin
C Jasmin is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Genetics and Immunology, having authored 58 papers that have together received 917 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Hematological disorders and diagnostics (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), T-cell and Retrovirus Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Hematology (170 citations), Oncology (364 citations), Immunology (194 citations), Genetics (81 citations) and Pathology and Forensic Medicine (93 citations). C Jasmin has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include L Schwarzenberg, Denis Clay, G Mathé, Florence Smadja‐Joffe, Bertrand Delpech, Yue Li, Christine Chomienne, N Balitrand, G Mathé and D. Machover. Their work appears in journals such as Journal of Clinical Oncology, Leukemia Research, The Lancet, Recent results in cancer research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.